(TheNewswire)
VANCOUVER, BC / TheNewswire / June 15, 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) ispleased to announce the following commentary on the growing globalfood security crisis on Yahoo Finance by Admiral James Stavridis,former Supreme Allied Commander, NATO, current Vice Chair, GlobalAffairs and Managing Director the Carlyle Group , and Chair of the Board of Trustees of the Rockefeller Foundation , along with recent testimony before the SenateAppropriations Subcommittee on Foreign Operations. As a result AREVLife Sciences Global Corporation announces the acceleration of itsefforts to bring SUSTAINN, a next-generation, Ready-to-Use-TherapeuticFood to market.
SUSTAINN is being developed in collaboration with TheRichardson Center for Functional Foods, University of Manitoba,TransBiotech, and key opinion leaders in biology, therapeuticdevelopment and clinical study design from the Institute of HumanVirology, University of Maryland and The Linus Pauling Center atOregon State University, is in compliance with WHO, andCodex-Alimentarious guidelines in 43 countries. RUTF’s are essentialtherapeutic interventions for the treatment of severe acutemalnutrition and currently account for more than US $300M in 2022 insales by more than 40 companies.( 1 ) SUSTAINN is being produced under GMP conditions, which meetrelevant export criteria, is aflatoxin free and designed to maintain ashelf life of up to two years under appropriate storage instructions.SUSTAINN provides optimal nutritional support addressing therestoration of gut microbiota, malabsorption associated with cachexia,provides essential nutrition, vitamins, minerals and protein thatencourage muscle retention, and metabolic functions including ATPlevels and EFA supplementation that encourages neurologicaldevelopment.
Global bilateral humanitarian contributions to foodsecurity for international relief currently exceed $64 billion withthe US
accounting for for 36% of total funding according tothe GAO ( 2 ) as of 2022outside of US Contributions to Humanitarian Efforts in the Ukraine andincluding contributions by both The World Bank and The InternationalMonetary Fund to address global food security Characteristic designof SUSTAINN involving proprietary extraction techniques developed byAREV Life Sciences, coupled with advanced analytical is intended toaddress the clinical consequences of serious acute malnutrition toaddress SAM.
SUSTAINN is intended to accelerate recovery from Severe AcuteMalnutrition (SAM) affecting more than 50 million children worldwidecausing 45% of deaths among children under 5 years. Childhood wastingis currently identified as the leading cause of death in children asof 2022. The impact is particularly significant on women and children,with more than 149 million children under the age of five affected bystunting and nearly 30 percent of women around the world between theages of 15 and 49 affected by anemia.
Mike Withrow, CEO of AREV Life Sciences stated “AREVLife Sciences is taking immediate measures to accelerate thedevelopment of SUSTAINN to meet expected market shortcomings, ashumanitarian relief efforts from the Sahel region to Europe haveevolved into a global security issue, challenging stability in over 40countries. The joint statement by the World Health Organization (WHO)and the WFP issued April 13, 2022, which supports of the goals of theGlobal Action Plan on Child Wasting issued November 2021 by UNICEF, insupport of the Sustainable Development Goals for the inclusion ofRUTFs into the WHO Essential Medicine List following therecommendations of the UNICEF Expert Meeting on RUTFs in September2019 encouraging the introduction of new formulas”.
During testimony by David Beasley, Executive Directorof the United Nations World Food Program. managing (BUDGET)( 3 ) on May 11 beforethe Senate Appropriations Subcommittee on Foreign OperationsSub-Committee David Beasley testified on the current status of thecontemporary famine. Beasley identified that famine and global foodinsecurity has to be addressed as a National security interest andthat 80 million people are now at risk for starvation and 810 millionare experiencing food insecurity.
U.S. Senator Chris Van Hollen (D-Md.) and Senator DickDurbin (D-Ill.) in a bipartisan letter to President Biden requestingan increase of the current $308 million in humanitarian aid, noting“The State of Food Security and Nutrition in the World, close to 12percent of the world’s population, representing 928 million people,faces severe food insecurity and 30 percent face at least moderatefood insecurity directing these additional funds, through theInternational Disaster Assistance account, Food for Peace Title II.This follows Rep. Austin Scott’s Bi-partisan Dear Colleague Letteron October 8 th 2021 requesting a baseline assessments of RUTF procurementand distribution to Samantha Power, USAID Administrator of the UnitedStates Agency for International Development which is managing a budget of $58.5 billion in 2022 ( 4 ). OnMay 19 th 2022, the House passed H.R. 7691, a bill that provides $5Billion in additional supplementary funding by the United States toaddress the crisis in Ukraine and its global impacts.
Roscoe Moore DVM, MPH, PhD, former US Asst. SurgeonGeneral (ret.), Member of AREV’s Scientific AdvisoryBoard , quote “The organoleptic evaluationof SUSTAINN is positioned to demonstrate significant improvement inthe delivery of bio-available nutrients critical for our confidence inthe forthcoming randomized, controlled, double-blind, non-inferiorityefficacy studies intended to provide affirmation of therapeuticeffect” .
AREV is focusing significant resources on developing aninitial concept sheet for paediatric studies of SUSTAINN in Low andMiddle Income Country “ LMIC ” settings with academic partners, engaging ininternational sourcing of ingredients suitable to accommodate expectedvolume, securing GMP manufacturing with vendors, consulting with theleadership of internationally recognized NGOs implementing faminerelief in PEPFAR designated countries currently receiving USAIDfinancing, and submitting product registration applications to globalhealth commodity procurement programs. The availability of RUTF’s insubstantial quality that can meet the unprecedented needs presented byrapidly diminishing global food security. Meetings at 22 nd World AIDSConference this July in Montreal are being secured with leadership ofinternational public health commodity procurement programs includingWFP, FAO, USAID, The Global Fund and PEPFAR.
For further information, contact Mike Withrow,arevlifesciences@gmail.com 778-929-6536. For more information visitwww.arevlifesciences.com.
On behalf of the Board,
Mike Withrow
CEO & Director
About AREV Life Sciences GlobalCorp.
AREV is an early-stage life science discoveryenterprise dedicated to delivering solutions to public health throughdiscovery, collaborations in the life science industry, and pathogenremediation. AREV is invested in commercial innovations inphytomedicinal discoveries of small molecule antivirals and forrelated neglected chronic co-morbidities and innovations humannutrition including the late-stage development of a Ready-to-UseTherapeutic Food (RUTF) for Severe Acute Malnutrition (SAM) and anEnteral Formula targeting the long-term effects of chronic infection.AREV is dedicated to designing and delivering innovation in rationaldrug design, driven by presenting global epidemiologicalcharacteristics of multiple challenges to international human andanimal health. AREV is a member of both BIOTECanada and TheBiotechnology Innovation Organization (BIO).
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITSREGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITYFOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in policies ofthe CSE) accepts responsibility for the adequacy or accuracy of thisrelease. This news release may include forward-looking statements thatare subject to risks and uncertainties. All statements within, otherthan statements of historical fact, are to be considered forwardlooking. Although the Company believes the expectations expressed insuch forward looking statements are based on reasonable assumptions,such statements are not guarantees of future performance and actualresults or developments may differ materially from those inforward-looking statements. Factors that could cause actual results todiffer materially from those in forward-looking statements includemarket prices, exploitation and exploration successes, and continuedavailability of capital and financing, and general economic, market orbusiness conditions. There can be no assurances that such statementswill prove accurate and, therefore, readers are advised to rely ontheir own evaluation of such uncertainties. We do not assume anyobligation to update any forward-looking statements except as required
under the applicable laws. This press release containsforward-looking statements. The use of any of the words"anticipate", "continue", "estimate","expect", "may", "will","project", "should", "believe" andsimilar expressions are intended to identify forward-lookingstatements. Although the Company believes that the expectations andassumptions on which the forward-looking statements are based arereasonable, undue reliance should not be placed on the forward-lookingstatements because the Company can give no assurance that they willprove to be correct. Since forward-looking statements
address future events and conditions, by their verynature they involve inherent risks and uncertainties. These statementsspeak only as of the date of this press release. Actual results coulddiffer materially from those currently anticipated due to a number offactors and risks various risk factors discussed in theCompany’ s Management ’sDiscussion and Analysis under the Company’s profile on www.sedar.com.
1 https://www.fmiblog.com/2022/02/09/ready-to-use-therapeutic-food-market-2022-latest-trends-demand-growth-opportunities-outlook-till-2030/
2 https://www.gao.gov/products/gao-21-47r Note : numbers are from 2018
Copyright (c) 2022 TheNewswire - All rights reserved.